Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | peptidylglycine monooxygenase | 0.0129 | 0.4364 | 0.4087 |
Onchocerca volvulus | 0.005 | 0.0468 | 0.5 | |
Mycobacterium ulcerans | Zn-dependent glyoxylase | 0.005 | 0.0468 | 0.5 |
Onchocerca volvulus | Putative hydrolase PNKD | 0.005 | 0.0468 | 0.5 |
Trypanosoma brucei | protein farnesyltransferase beta subunit | 0.0056 | 0.0752 | 0.5127 |
Mycobacterium ulcerans | hypothetical protein | 0.005 | 0.0468 | 0.5 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0056 | 0.0752 | 1 |
Chlamydia trachomatis | ribonuclease Z | 0.005 | 0.0468 | 0.5 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0056 | 0.0752 | 1 |
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0056 | 0.0752 | 1 |
Plasmodium vivax | unspecified product | 0.005 | 0.0468 | 0.6232 |
Mycobacterium leprae | conserved hypothetical protein | 0.005 | 0.0468 | 0.5 |
Treponema pallidum | ribonuclease Z | 0.005 | 0.0468 | 0.5 |
Mycobacterium ulcerans | beta lactamase-like protein | 0.005 | 0.0468 | 0.5 |
Mycobacterium leprae | POSSIBLE HYDROLASE | 0.005 | 0.0468 | 0.5 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.0056 | 0.0752 | 0.0297 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0065 | 0.122 | 0.0789 |
Echinococcus granulosus | protein farnesyltransferase subunit beta | 0.0056 | 0.0752 | 0.0297 |
Leishmania major | metallo-beta-lactamase family protein-like protein | 0.005 | 0.0468 | 0.4129 |
Trichomonas vaginalis | type I geranylgeranyltransferase beta subunit, putative | 0.0056 | 0.0752 | 1 |
Mycobacterium ulcerans | hydrolase | 0.005 | 0.0468 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.005 | 0.0468 | 0.5 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0056 | 0.0752 | 1 |
Mycobacterium leprae | Beta-lactamase-like protein | 0.005 | 0.0468 | 0.5 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0061 | 0.1021 | 1 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0056 | 0.0752 | 0.5127 |
Leishmania major | cleavage and polyadenylation specificity factor, putative | 0.005 | 0.0468 | 0.4129 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.0056 | 0.0752 | 1 |
Trichomonas vaginalis | geranylgeranyl transferase type beta subunit, putative | 0.0056 | 0.0752 | 1 |
Onchocerca volvulus | Hydroxyacylglutathione hydrolase, mitochondrial homolog | 0.005 | 0.0468 | 0.5 |
Leishmania major | farnesyltransferase beta subunit | 0.0056 | 0.0752 | 1 |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.0056 | 0.0752 | 0.0297 |
Mycobacterium ulcerans | hypothetical protein | 0.005 | 0.0468 | 0.5 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0056 | 0.0752 | 1 |
Leishmania major | metallo-beta-lactamase family-like protein | 0.005 | 0.0468 | 0.4129 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0056 | 0.0752 | 0.0297 |
Mycobacterium ulcerans | hypothetical protein | 0.005 | 0.0468 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0129 | 0.4364 | 0.4087 |
Mycobacterium tuberculosis | Halimadienyl diphosphate synthase | 0.0061 | 0.1021 | 1 |
Trypanosoma brucei | lanosterol synthase | 0.0061 | 0.1021 | 1 |
Leishmania major | hypothetical protein, conserved | 0.005 | 0.0468 | 0.4129 |
Plasmodium vivax | hydroxyacyl glutathione hydrolase, putative | 0.005 | 0.0468 | 0.6232 |
Wolbachia endosymbiont of Brugia malayi | metallo-beta-lactamase superfamily hydrolase | 0.005 | 0.0468 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0242 | 1 | 1 |
Echinococcus multilocularis | protein farnesyltransferase subunit beta | 0.0056 | 0.0752 | 0.0297 |
Entamoeba histolytica | protein farnesyltransferase beta subunit, putative | 0.0056 | 0.0752 | 1 |
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.0242 | 1 | 1 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0056 | 0.0752 | 0.5127 |
Mycobacterium ulcerans | glyoxalase II, GloB | 0.005 | 0.0468 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.005 | 0.0468 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.005 | 0.0468 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0063 | 0.1125 | 0.0689 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0061 | 0.1021 | 1 |
Giardia lamblia | Prenyltransferase | 0.0056 | 0.0752 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.4364 | 0.4087 |
Schistosoma mansoni | peptidyl-glycine monooxygenase | 0.0242 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.005 | 0.0468 | 0.5 |
Leishmania major | hydroxyacylglutathione hydrolase, putative,glyoxalase II, putative | 0.005 | 0.0468 | 0.4129 |
Schistosoma mansoni | dopamine-beta-monooxygenase | 0.0129 | 0.4364 | 0.4087 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0056 | 0.0752 | 1 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.0242 | 1 | 1 |
Onchocerca volvulus | 0.005 | 0.0468 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 0 | Antiproliferative activity against human SK-N-MC cells by MTT assay | ChEMBL. | 17904844 |
IC50 (functional) | = 10.31 uM | Antiproliferative activity against mouse P388 cells by MTT assay | ChEMBL. | 17904844 |
IC50 (functional) | = 10.31 uM | Antiproliferative activity against mouse P388 cells by MTT assay | ChEMBL. | 17904844 |
LC50 (ADMET) | 0 | Cytotoxicity against rat N-ras transformed NRK N/4.2 cells after 5 days | ChEMBL. | 17035024 |
LC50 (ADMET) | = 0.6 uM | Cytotoxicity against rat H-ras transformed NRK H/1.2 cells after 5 days | ChEMBL. | 17035024 |
LC50 (ADMET) | = 0.8 uM | Cytotoxicity against rat NRK 52E cells after 5 days | ChEMBL. | 17035024 |
LC50 (ADMET) | = 0.8 uM | Cytotoxicity against mouse 3LL cells after 5 days | ChEMBL. | 17035024 |
LC50 (ADMET) | = 1.3 uM | Cytotoxicity against rat K-ras transformed NRK K/1 cells after 5 days | ChEMBL. | 17035024 |
log K | 0 | Lipophilicity, log K of the compound | ChEMBL. | 17904844 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 17904844 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.